FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/08/035331 [Registered on: 02/08/2021] Trial Registered Prospectively
Last Modified On: 31/07/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Non-randomized, Multiple Arm Trial 
Public Title of Study   Assessing the Feasibility and Impact of Physical Health Monitoring in Patients with First Episode Psychosis (AIIMS centre) 
Scientific Title of Study   Assessing the Feasibility and Impact of Physical Health Monitoring in Patients with First Episode Psychosis (AIIMS centre) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rakesh Kumar Chadda 
Designation  HOD Dept Of Psychiatry and NDDTC AIIMS 
Affiliation  AIIMS NEW DELHI 
Address  Room no 4084 4th floor Teaching block Dept of psychiatry New Delhi

South
DELHI
110029
India 
Phone  011-26593245  
Fax    
Email  drrakeshchadda@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rakesh Kumar Chadda 
Designation  HOD Dept Of Psychiatry and NDDTC AIIMS 
Affiliation  AIIMS NEW DELHI 
Address  Room no 4084 4th floor Teaching block Dept of psychiatry New Delhi

South
DELHI
110029
India 
Phone  011-26593245  
Fax    
Email  drrakeshchadda@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rakesh Kumar Chadda 
Designation  HOD Dept Of Psychiatry and NDDTC AIIMS 
Affiliation  AIIMS NEW DELHI 
Address  Room no 4084 4th floor Teaching block Dept of psychiatry New Delhi

South
DELHI
110029
India 
Phone  011-26593245  
Fax    
Email  drrakeshchadda@gmail.com  
 
Source of Monetary or Material Support  
National Institute for Health Research ,U.K. 
 
Primary Sponsor  
Name  National Institute for Health Research  
Address  National Institute for Health Research Evaluation, trials and Studies Coordinating Centre University of Southampton Alpha House, Enterprise Road Southampton, SO16 7NS 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
RAKESH KUMAR CHADDA  Out-patient settings, Department of Psychiatry, AIIMS, New Delhi  ANSARI NAGAR, NEW DELHI
South
DELHI 
011-26593245

drrakeshchadda@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, AIIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F302||Manic episode, severe with psychotic symptoms, (2) ICD-10 Condition: F323||Major depressive disorder, singleepisode, severe with psychotic features, (3) ICD-10 Condition: F20||Schizophrenia, (4) ICD-10 Condition: F22||Delusional disorders, (5) ICD-10 Condition: F23||Brief psychotic disorder, (6) ICD-10 Condition: F25||Schizoaffective disorders, (7) ICD-10 Condition: F28||Other psychotic disorder not due to a substance or known physiological condition, (8) ICD-10 Condition: F29||Unspecified psychosis not due to asubstance or known physiological condition,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Booklet-based intervention arm  Psychoeducation booklets and physical health monitoring used to provide psychosocial intervention for three months. Assessment will be done at baseline, 1 month and 3 months  
Intervention  Mobile-app based intervention arm  Mobile app developed for physical health monitoring and psychoeducation. Intervention with mobile app will be provided for three months. Assessment will be done at baseline, 1 month and 3 months 
Comparator Agent  Treatment as usual arm  Standard routine care given at AIIMS, New Delhi. No additional intervention will be given. Assessment will be done at baseline, 1 month and 3 months 
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  Inclusion criteria for Patient
ï‚· First presentation with psychotic symptoms at our centre
ï‚· Age 14-45 years
ï‚· No past history of psychosis
 Not received treatment ≥ 3 months
ï‚· Either sex
ï‚· Schizophrenia (F20), persistent delusional disorder (F22), acute and transient psychotic disorders (F 23), Schizo-affective disorder (F25), Other and Unspecified Psychosis (F28 & F29), Mania with psychotic symptoms (F30.2), Bipolar affective disorder, current episode manic with psychotic symptoms (F 31.2), Severe depressive
episode with psychotic symptoms (F32.3) and Recurrent Depressive Disorder, current episode depression with psychotic symptoms (F 33.3) on ICD-10 (WHO 1993).


Inclusion criteria for Caregiver
A family member staying with patient and fulfilling any three of the following criteria (Maji et al, 2012):
ï‚· Parent or spouse
ï‚· Had most frequent contact with the patient
ï‚· Helped to support the patient financially
 Had most frequently been a participant in patient’s treatment
ï‚· To be contacted by treatment staff in case of an emergency 
 
ExclusionCriteria 
Details  Exclusion criteria for Patient
ï‚· Presence of pervasive developmental disorder, specific learning disability and mental retardation (ascertained on history and clinical examination)
ï‚· Presence of organic brain damage, epilepsy (ascertained on history and clinical examination)
ï‚· Not willing or able to provide informed consent

Exclusion criteria for Caregivers
ï‚· Not willing/or able to provide informed consent 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
SAPS,SANS, YMRS, MADRS,BPRS, GAF, SOFAS, EQ 5 D 5L, Assessment of Physical Health Checklist

Weight, Height, BMI, Waist Circumference, Hip Circumference, Waist–to-Hip Ratio, Blood Pressure

-Laboratory Investigations: ECG, haematology, liver function test, kidney function test, urine examination (for proteinuria and microalbuminuria), lipid profiling, fasting glucose and fasting insulin ( for Insulin Resistance ), HbA1C

 
baseline, 1 month, 3 month 
 
Secondary Outcome  
Outcome  TimePoints 
Food taking patterns
Feasibility performa  
baseline, 1 month, 3 month 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   16/08/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is a multicentric multicountry project funded by National Institute for Health Research, UK titled multicentric multicountry project funded by National Institute for Health Research, UK titled “NIHR Global Health Research Group on Psychosis Outcomes: the Warwick-India- Canada (WIC) Network, The University of Warwick”.The objectives of the project at AIIMS center are to determine prevalence of cardiometabolic risk factors such as metabolic syndrome, insulin resistance, prediabetes in a cohort of FEP patients and to assess feasibility and acceptability of using mobile app and booklet based psychosocial intervention protocols in patients with FEP in promoting adherence to healthy lifestyle and impact on outcomes (psychopathology, food taking patterns, physical activity and physical health parameters, functioning and quality of life).The Project aims to improve the physical health, wellbeing and functioning, and reduce the burden for patients with first episode psychosis. It aims to do this by applying using mobile app and booklet based psychosocial intervention protocols in patients with FEP. 
Close